Last updated: 3 April 2024 at 4:51pm EST

Karen Sue Lynch Net Worth




The estimated Net Worth of Karen S Lynch is at least $45.5 millió dollars as of 3 May 2023. Ms Lynch owns over 14,000 units of CVS Health Corp stock worth over $24,205,405 and over the last 19 years she sold CVS stock worth over $17,456,791. In addition, she makes $3,836,578 as Pres és CEO & Director at CVS Health Corp.

Ms Lynch CVS stock SEC Form 4 insiders trading

Ms has made over 19 trades of the CVS Health Corp stock since 2006, according to the Form 4 filled with the SEC. Most recently she bought 14,000 units of CVS stock worth $976,500 on 3 May 2023.

The largest trade she's ever made was selling 80,143 units of CVS Health Corp stock on 18 November 2019 worth over $6,010,725. On average, Ms trades about 4,956 units every 90 days since 2006. As of 3 May 2023 she still owns at least 431,392 units of CVS Health Corp stock.

You can see the complete history of Ms Lynch stock trades at the bottom of the page.





Ms. Karen Sue Lynch biography

Karen Sue Lynch is the Pres, CEO & Director at CVS Health Corp.

What is the salary of Ms Lynch?

As the Pres és CEO & Director of CVS Health Corp, the total compensation of Ms Lynch at CVS Health Corp is $3,836,578. There are 7 executives at CVS Health Corp getting paid more, with Larry Merlo having the highest compensation of $36,451,700.



How old is Ms Lynch?

Ms Lynch is 58, she's been the Pres és CEO & Director of CVS Health Corp since . There are 19 older and 9 younger executives at CVS Health Corp. The oldest executive at CVS Health Corp is Tony White, 73, who is the Independent Director.

What's Ms Lynch's mailing address?

Karen's mailing address filed with the SEC is CVS Drive, Woonsocket, Providence County, Rhode Island, 02895, United States.

Insiders trading at CVS Health Corp

Over the last 22 years, insiders at CVS Health Corp have traded over $183,836,314 worth of CVS Health Corp stock and bought 424,315 units worth $17,621,990 . The most active insiders traders include Michael F Mahoney, Thomas M Ryan és Larry J Merlo. On average, CVS Health Corp executives and independent directors trade stock every 25 days with the average trade being worth of $4,897,842. The most recent stock trade was executed by Edward J Ludwig on 2 May 2024, trading 1,000 units of CVS stock currently worth $53,880.



What does CVS Health Corp do?

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.



What does CVS Health Corp's logo look like?

CVS Health Corp logo

Complete history of Ms Lynch stock trades at Magellan Health Inc, Cigna, CVS Health Corp és U.S. Bancorp

Dátum
#
Cég
Az érdekelt
Trans.
Tranzakció
Részvények száma Ár per részvény Teljes ár Részvények szíma után Forrás
3 May 2023 Karen S Lynch
elnök és CEO
Megvenni 14,000 $69.75 $976,500
3 May 2023
431,392
18 Nov 2019 Karen S Lynch
elnök és CEO
Eladás 80,143 $75.00 $6,010,725
18 Nov 2019
41,831
3 Mar 2012 Karen S Lynch
elnök
Opció Gyakorlat 5,551 $47.02 $261,008
3 Mar 2012
7,521
2 Sep 2011 Karen S Lynch
elnök
Eladás 20,100 $47.53 $955,353
2 Sep 2011
1,970
1 Sep 2011 Karen S Lynch
elnök
Eladás 11,900 $49.39 $587,741
1 Sep 2011
1,970
26 Apr 2011 Karen S Lynch
elnök
Eladás 16,500 $50.25 $829,125
26 Apr 2011
0
8 Apr 2011 Karen S Lynch
elnök
Eladás 500 $50.01 $25,005
8 Apr 2011
0
8 Apr 2011 Karen S Lynch
elnök
Eladás 500 $50.01 $25,005
8 Apr 2011
0
3 Mar 2011 Karen S Lynch
elnök
Opció Gyakorlat 2,927 $49.10 $143,716
3 Mar 2011
2,927
1 Jun 2007 Karen S Lynch
elnök és Group Ins.
Opció Gyakorlat 6,451 $92.81 $598,717
1 Jun 2007
17,191
16 Mar 2007 Karen S Lynch
elnök és Group Ins.
Opció Gyakorlat 2,707 $55.44 $150,076
16 Mar 2007
12,324
16 Feb 2007 Karen S Lynch
elnök és Group Ins.
Opció Gyakorlat 3,333 $41.09 $136,953
16 Feb 2007
11,413
2 Mar 2006 Karen S Lynch
elnök és Group Ins.
Opció Gyakorlat 7,631 $58.63 $447,406
2 Mar 2006
14,833


CVS Health Corp executives and stock owners

CVS Health Corp executives and other stock owners filed with the SEC include: